Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003758]
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003758]
Bio2RDF identifier
NCT00003758
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00003758
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... e myelogenous
leukemia.
brief title [clinicaltrials_vocabulary:brief-title]
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Assess t ...... ll be accrued for this study.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
adult acute basophilic leukemia
adult acute eosinophilic leukemia
adult acute erythroid leukemia (M6)
adult acute megakaryoblastic leukemia (M7)
adult acute minimally differentiated myeloid leukemia (M0)
adult acute monoblastic leukemia and acute monocytic leukemia (M5)
adult acute myeloblastic leukemia with maturation (M2)
adult acute myeloblastic leukemia without maturation (M1)
adult acute myelomonocytic leukemia (M4)
childhood acute basophilic leukemia
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2009-02-06T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00003758
official title [clinicaltrials_vocabulary:official-title]
Treatment of Relapsed Acute My ...... hase II Study by the EORTC-LCG
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000066882
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
EORTC-06956
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1998-12-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2001-01-01T00:00:00Z
identifier
clinicaltrials:NCT00003758
title
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
@en
type
label
Combination Chemotherapy in Tr ...... a [clinicaltrials:NCT00003758]
@en